Works by Arnott, Clare

Results: 66

The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials.

Published in:

Journal of the American Geriatrics Society, 2025, v. 73, n. 6, p. 1787, doi. 10.1111/jgs.19444

By:

Nguyen, Tu N.;
Yu, Jie;
Perkovic, Vlado;
Jardine, Meg;
Mahaffey, Kenneth W.;
Chow, Clara K.;
Arnott, Clare;
Lindley, Richard I.

Publication type:

Article

The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study.

Published in:

European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-02214-7

By:

Yang, Hao;
Yang, Lili;
Jardine, Meg J.;
Arnott, Clare;
Neuen, Brendon L.;
Xu, Kexi;
Zhao, Xiaohui;
Qian, Dehui;
Cui, Bin;
Qiu, Youzhu;
Huang, Yuli;
Yu, Jie;
Wang, Jiang;
Yu, Shiyong;
Tan, Hu;
Huang, Lan;
Li, Jing-Wei;
Jin, Jun

Publication type:

Article

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3531, doi. 10.1111/dom.16363

By:

Zhu, Ying;
Jun, Min;
Fletcher, Robert A.;
Arnott, Clare;
Neuen, Brendon L.;
Kotwal, Sradha S.

Publication type:

Article

Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1972, doi. 10.1111/dom.16190

By:

Siriwardana, Amanda;
Buizen, Luke;
Jun, Min;
Kotwal, Sradha;
Arnott, Clare;
Jardine, Meg J.;
Levin, Adeera;
Heerspink, Hiddo J. L.;
Charytan, David M.;
Pollock, Carol;
Perkovic, Vlado;
Neuen, Brendon L.

Publication type:

Article

An overview of the CANVAS Program and CREDENCE trial: The primary outcomes and key clinical implications for those managing patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, p. 5, doi. 10.1111/dom.15751

By:

Chen, Angela X.;
Fletcher, Robert;
Neuen, Brendon L.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685

By:

Cardoza, Kathryn;
Kang, Amy;
Smyth, Brendan;
Yi, Tae Won;
Pollock, Carol;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Wheeler, David C.;
Zhang, Hong;
Cannon, Christopher P.;
Perkovic, Vlado;
Arnott, Clare;
Levin, Adeera;
Mahaffey, Kenneth W.

Publication type:

Article

Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678

By:

Tangri, Navdeep;
Ferguson, Thomas W.;
Bamforth, Ryan J.;
Leon, Silvia J.;
Arnott, Clare;
Mahaffey, Kenneth W.;
Kotwal, Sradha;
Heerspink, Hiddo J. L.;
Perkovic, Vlado;
Fletcher, Robert A.;
Neuen, Brendon L.

Publication type:

Article

Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2741, doi. 10.1111/dom.15592

By:

Said, Fatema;
Arnott, Clare;
Voors, Adriaan A.;
Heerspink, Hiddo J. L.;
ter Maaten, Jozine M.

Publication type:

Article

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340

By:

Sharma, Abhinav;
Marques, Pedro;
Neuen, Brendon L.;
Fletcher, Robert A.;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Arnott, Clare;
Levin, Adeera;
Verma, Subodh;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3724, doi. 10.1111/dom.15267

By:

Yu, Jie;
Sweeting, Arianne N.;
Gianacas, Chris;
Houston, Lauren;
Lee, Vivian;
Fletcher, Robert A.;
Perkovic, Vlado;
Li, Qiang;
Neuen, Brendon L.;
Berwanger, Otavio;
Heerspink, Hiddo J. L.;
de Zeeuw, Dick;
Arnott, Clare

Publication type:

Article

Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2331, doi. 10.1111/dom.15112

By:

Sridhar, Vikas S.;
Neuen, Brendon L.;
Fletcher, Robert A.;
Slee, April;
Ang, Fernando G.;
Rapattoni, Wally;
Arnott, Clare;
Cherney, David Z.;
Perkovic, Vlado;
Wheeler, David C.;
Levin, Adeera

Publication type:

Article

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091

By:

Kang, Amy;
Smyth, Brendan;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Di Tanna, Gian Luca;
Zhang, Hong;
Arnott, Clare;
Hockham, Carinna;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Greene, Tom;
Levin, Adeera;
Pollock, Carol;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Jardine, Meg J.

Publication type:

Article

Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065

By:

Yi, Tae Won;
Wong, Michelle M.Y.;
Neuen, Brendon L.;
Arnott, Clare;
Poirier, Paul;
Seufert, Jochen;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Levin, Adeera

Publication type:

Article

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2038, doi. 10.1111/dom.15057

By:

Tsoukas, Michael A.;
Woo, Vincent;
Tobe, Sheldon W.;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Seufert, Jochen;
Neuen, Brendon L.;
Arnott, Clare;
Mahaffey, Kenneth W.;
Wheeler, David C.

Publication type:

Article

The importance of targeting multiple risk markers in patients with type 2 diabetes: A post‐hoc study from the CANVAS programme.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1638, doi. 10.1111/dom.15018

By:

Tye, SokCin;
Oshima, Megumi;
Arnott, Clare;
Neuen, Brendon L.;
Fletcher, Robert A.;
Neal, Bruce;
Heerspink, Hiddo J. L.

Publication type:

Article

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978

By:

Koshino, Akihiko;
Oshima, Megumi;
Arnott, Clare;
Fletcher, Robert A.;
Bakris, George L.;
Jardine, Meg;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Pollock, Carol;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.

Publication type:

Article

Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832

By:

Nunes, Julio C.;
Yu, Jie;
Arnott, Clare;
Jardine, Meg J.;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

Mechanisms of action of the sodium‐glucose cotransporter‐2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1950, doi. 10.1111/dom.14779

By:

Sen, Taha;
Koshino, Akihiko;
Neal, Bruce;
Bijlsma, Maarten J.;
Arnott, Clare;
Li, Jingwei;
Hansen, Michael K.;
Ix, Joachim H.;
Heerspink, Hiddo J. L.

Publication type:

Article

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772

By:

Li, Chao;
Yu, Jie;
Hockham, Carinna;
Perkovic, Vlado;
Neuen, Brendon L.;
Badve, Sunil V.;
Houston, Lauren;
Lee, Vivian Y. J.;
Barraclough, Jennifer Y.;
Fletcher, Robert A.;
Mahaffey, Kenneth W.;
Heerspink, Hiddo J. L.;
Cannon, Christopher P.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671

By:

Barraclough, Jennifer Y.;
Yu, Jie;
Figtree, Gemma A.;
Perkovic, Vlado;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.;
Cannon, Christopher P.;
Mahaffey, Kenneth W.;
Schutte, Aletta E.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386

By:

Arnott, Clare;
Li, Jing‐Wei;
Cannon, Christopher P.;
Zeeuw, Dick;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Charytan, David M.;
Agarwal, Anubha;
Huffman, Mark D.;
Figtree, Gemma A.;
Bakris, George;
Chang, Tara I‐Hsin;
Feng, Kent;
Rosenthal, Norman;
Zinman, Bernard;
Jardine, Meg J.;
Perkovic, Vlado;
Neal, Bruce;
Mahaffey, Kenneth W.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226

By:

Neuen, Brendon L.;
Arnott, Clare;
Perkovic, Vlado;
Figtree, Gemma;
Zeeuw, Dick;
Fulcher, Greg;
Jun, Min;
Jardine, Meg J.;
Zoungas, Sophia;
Pollock, Carol;
Mahaffey, Kenneth W.;
Neal, Bruce;
Heerspink, Hiddo J. L.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197

By:

Li, Chao;
Zhou, Zien;
Neuen, Brendon L.;
Yu, Jie;
Huang, Yuli;
Young, Tamara;
Li, Jingwei;
Li, Lin;
Perkovic, Vlado;
Jardine, Meg J.;
Keay, Lisa;
Markoulli, Maria;
Rosenthal, Norm;
Capuano, George;
Yavin, Yshai;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091

By:

Arnott, Clare;
Huang, Yuli;
Neuen, Brendon L;
Di Tanna, Gian Luca;
Cannon, Christopher P.;
Oh, Richard;
Edwards, Robert;
Kavalam, Mary;
Rosenthal, Norman;
Perkovic, Vlado;
Jardine, Meg J;
Mahaffey, Kenneth;
Neal, Bruce

Publication type:

Article

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01619-0

By:

Tye, Sok Cin;
Jongs, Niels;
Coca, Steven G.;
Sundström, Johan;
Arnott, Clare;
Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Vart, Priya;
Heerspink, Hiddo. J. L.

Publication type:

Article

The long‐term cardiovascular impact of hypertension in pregnancy – A missed opportunity.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2021, v. 61, n. 3, p. 474, doi. 10.1111/ajo.13335

By:

Davis, Gregory K.;
Henry, Amanda;
Arnott, Clare;
Brown, Mark A.

Publication type:

Article

The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms.

Published in:

Cells (2073-4409), 2021, v. 10, n. 10, p. 2699, doi. 10.3390/cells10102699

By:

Barraclough, Jennifer Y.;
Patel, Sanjay;
Yu, Jie;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER.

Published in:

European Heart Journal, 2023, v. 44, n. 24, p. 2184, doi. 10.1093/eurheartj/ehad315

By:

Arnott, Clare;
Neal, Bruce

Publication type:

Article

Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm.

Published in:

2021

By:

Golledge, Jonathan;
Arnott, Clare;
Moxon, Joseph;
Monaghan, Helen;
Norman, Richard;
Morris, Dylan;
Li, Qiang;
Jones, Greg;
Roake, Justin;
Bown, Matt;
Neal, Bruce

Publication type:

journal article

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.

Published in:

2022

By:

Koshino, Akihiko;
Schechter, Meir;
Sen, Taha;
Vart, Priya;
Neuen, Brendon L.;
Neal, Bruce;
Arnott, Clare;
Perkovic, Vlado;
Ridker, Paul M.;
Tuttle, Katherine R.;
Hansen, Michael K.;
Heerspink, Hiddo J.L.

Publication type:

journal article

Effectiveness of an online food shopping intervention to reduce salt purchases among individuals with hypertension – findings of the SaltSwitch Online Grocery Shopping (OGS) randomised trial.

Published in:

International Journal of Behavioral Nutrition & Physical Activity, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12966-024-01700-9

By:

Wu, Jason HY;
Maganja, Damian;
Huang, Liping;
Trieu, Kathy;
Taylor, Fraser;
Barrett, Eden M.;
Arnott, Clare;
Feng, Xiaoqi;
Schutte, Aletta E.;
Di Tanna, Gian Luca;
Mhurchu, Cliona Ni;
Cameron, Adrian J.;
Huffman, Mark D.;
Neal, Bruce

Publication type:

Article

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Published in:

2020

By:

Arnott, Clare;
Qiang Li;
Kang, Amy;
Neuen, Brendon L.;
Bompoint, Severine;
Lam, Carolyn S. P.;
Rodgers, Anthony;
Mahaffey, Kenneth W.;
Cannon, Christopher P.;
Perkovic, Vlado;
Jardine, Meg J.;
Neal, Bruce;
Li, Qiang

Publication type:

journal article

The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells.

Published in:

PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150688

By:

Arnott, Clare;
Punnia-Moorthy, Gaya;
Tan, Joanne;
Sadeghipour, Sara;
Bursill, Christina;
Patel, Sanjay

Publication type:

Article

Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.

Published in:

Cardiovascular Research, 2022, v. 118, n. 4, p. 1103, doi. 10.1093/cvr/cvab128

By:

Yu, Jie;
Li, Jingwei;
Leaver, Phillip J;
Arnott, Clare;
Huffman, Mark D;
Udell, Jacob A;
Perkovic, Vlado;
Mahaffey, Kenneth W;
Zeeuw, Dick de;
Fulcher, Greg;
Matthews, David R;
Shaw, Wayne;
Rosenthal, Norman;
Neal, Bruce;
Figtree, Gemma A

Publication type:

Article

"It's like a forgotten issue sometimes ...": Qualitative study of individuals living and caring for people with chronic breathlessness.

Published in:

Clinical Respiratory Journal, 2023, v. 17, n. 7, p. 694, doi. 10.1111/crj.13652

By:

Sunjaya, Anthony;
Martin, Allison;
Arnott, Clare;
Marks, Guy;
Jenkins, Christine

Publication type:

Article

Acceptability and feasibility of a chronic breathlessness diagnostic clinical algorithm in Australian primary care.

Published in:

Australian Journal of General Practice, 2024, p. S89, doi. 10.31128/ajgp-11-23-7009

By:

Sunjaya, Anthony Paulo;
Martin, Allison;
Arnott, Clare;
Di Tanna, Gian Luca;
Gianacas, Chris;
Marks, Guy;
Jenkins, Christine

Publication type:

Article

Knowledge, attitudes, and behaviors related to dietary salt intake and the acceptability of salt substitute among the Australian culturally and linguistically diverse community: An online survey.

Published in:

Journal of Clinical Hypertension, 2024, v. 26, n. 5, p. 543, doi. 10.1111/jch.14802

By:

Yu, Jie;
Houston, Lauren;
Gianacas, Chris;
Lee, Vivian;
Fletcher, Robert A.;
Chen, Angela Xun‐Nan;
Arnott, Clare

Publication type:

Article

Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.

Published in:

2020

By:

Thout, Sudhir Raj;
Yu, Jie;
Tian, Maoyi;
Huffman, Mark D.;
Arnott, Clare;
Li, Qiang;
Devarsetty, Praveen;
Johnson, Claire;
Pettigrew, Simone;
Neal, Bruce;
Wu, Jason H. Y.

Publication type:

journal article

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.

Published in:

Journal of the American Heart Association, 2024, v. 13, n. 3, p. 1, doi. 10.1161/JAHA.123.031586

By:

Sharma, Abhinav;
Razaghizad, Amir;
Joury, Abdulaziz;
Levin, Adeera;
Bajaj, Harpreet S.;
Mancini, G. B. John;
Wong, Norman C.;
Slee, April;
Ang, Fernando G.;
Rapattoni, Wally;
Neuen, Brendon L.;
Arnott, Clare;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.

Published in:

Journal of the American Heart Association, 2023, v. 12, n. 13, p. 1, doi. 10.1161/JAHA.122.028516

By:

Fletcher, Robert A.;
Arnott, Clare;
Rockenschaub, Patrick;
Schutte, Aletta E.;
Carpenter, Lewis;
Vaduganathan, Muthiah;
Agarwal, Rajiv;
Bakris, George;
Chang, Tara I.;
Heerspink, Hiddo J. L.;
Jardine, Meg J.;
Mahaffey, Kenneth W.;
Neal, Bruce;
Pollock, Carol;
Jun, Min;
Rodgers, Anthony;
Perkovic, Vlado;
Neuen, Brendon L.

Publication type:

Article

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial.

Published in:

2022

By:

Jing‐Wei Li;
Arnott, Clare;
Heerspink, Hiddo J. L.;
Qiang Li MBiostat;
Cannon, Christopher P.;
Wheeler, David C.;
Charytan, David M.;
Barraclough, Jennifer;
Figtree, Gemma A.;
Agarwal, Rajiv;
Bakris, George;
de Zeeuw, Dick;
Greene, Tom;
Levin, Adeera;
Pollock, Carol;
Zhang, Hong;
Zinman, Bernard;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Neal, Bruce

Publication type:

journal article

Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.

Published in:

2021

By:

Taha Sen;
Jingwei Li;
Neuen, Brendon L.;
Arnott, Clare;
Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Shaw, Wayne;
Canovatchel, William;
Hansen, Michael K.;
Heerspink, Hiddo J. L.;
Sen, Taha;
Li, Jingwei

Publication type:

journal article

Associations of Breast Arterial Calcifications with Cardiovascular Disease.

Published in:

Journal of Women's Health (15409996), 2023, v. 32, n. 5, p. 529, doi. 10.1089/jwh.2022.0394

By:

Ibrahim, Mu'ath;
Suleiman, Mo'ayyad E.;
Gandomkar, Ziba;
Tavakoli Taba, Amir;
Arnott, Clare;
Jorm, Louisa;
Barraclough, Jennifer Y.;
Barbieri, Sebastiano;
Brennan, Patrick C.

Publication type:

Article

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.

Published in:

Diabetologia, 2025, v. 68, n. 3, p. 507, doi. 10.1007/s00125-024-06325-y

By:

de Vries, Sieta T.;
Pena, Michelle J.;
Tye, Sok Cin;
Peters, Sanne A. E.;
van Raalte, Daniël H.;
Arnott, Clare;
Voors, Adriaan A.;
Mol, Peter G. M.;
Denig, Petra;
Heerspink, Hiddo J. L.

Publication type:

Article

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program.

Published in:

Diabetologia, 2021, v. 64, n. 11, p. 2402, doi. 10.1007/s00125-021-05524-1

By:

Young, Tamara K.;
Li, Jing-Wei;
Kang, Amy;
Heerspink, Hiddo J. L.;
Hockham, Carinna;
Arnott, Clare;
Neuen, Brendon L.;
Zoungas, Sophia;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
de Zeeuw, Dick;
Fulcher, Greg;
Neal, Bruce;
Jardine, Meg

Publication type:

Article

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.

Published in:

Diabetologia, 2021, v. 64, n. 10, p. 2147, doi. 10.1007/s00125-021-05512-5

By:

Sen, Taha;
Li, Jingwei;
Neuen, Brendon L.;
Neal, Bruce;
Arnott, Clare;
Parikh, Chirag R.;
Coca, Steven G.;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Yavin, Yshai;
Rosenthal, Norman;
Hansen, Michael K.;
Heerspink, Hiddo J. L.

Publication type:

Article

Canagliflozin and iron metabolism in the CREDENCE trial.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 696, doi. 10.1093/ndt/gfae198

By:

Koshino, Akihiko;
Heerspink, Hiddo J L;
Jongs, Niels;
Badve, Sunil V;
Arnott, Clare;
Neal, Bruce;
Jardine, Meg;
Mahaffey, Kenneth W;
Pollock, Carol;
Perkovic, Vlado;
Hansen, Michael K;
Bakker, Stephan J L;
Wada, Takashi;
Neuen, Brendon L

Publication type:

Article

Optimising mothers' health behaviour after hypertensive disorders of pregnancy: a qualitative study of a postnatal intervention.

Published in:

2022

By:

Rossiter, Chris;
Henry, Amanda;
Roberts, Lynne;
Brown, Mark A.;
Gow, Megan;
Arnott, Clare;
Salisbury, Justine;
Ruhotas, Annette;
Hehir, Angela;
Denney-Wilson, Elizabeth

Publication type:

journal article

Predicting Contrast-Associated Acute Kidney Injury.

Published in:

JAMA Network Open, 2025, v. 8, n. 3, p. e250107, doi. 10.1001/jamanetworkopen.2025.0107

By:

Feng, Yunlin;
Jun, Min;
Wang, Amanda Y.;
Ren, Song;
Weisbord, Steven D.;
Bellomo, Rinaldo;
Ostermann, Marlies;
Arnott, Clare;
Gallagher, Martin

Publication type:

Article

Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program.

Published in:

ESC Heart Failure, 2021, v. 8, n. 2, p. 1482, doi. 10.1002/ehf2.13236

By:

Yu, Jie;
Arnott, Clare;
Neuen, Brendon L.;
Heersprink, Hiddo L.;
Mahaffey, Kenneth W.;
Cannon, Christopher P.;
Khan, Sadiya S.;
Baldridge, Abigail S.;
Shah, Sanjiv J.;
Huang, Yuli;
Li, Chao;
Figtree, Gemma A.;
Perkovic, Vlado;
Jardine, Meg J.;
Neal, Bruce;
Huffman, Mark D.

Publication type:

Article